Imricor Medical Systems Inc (ASX:IMR) chair and CEO Steve Wedan speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020.
Imricor Announces Sales Collaboration with Optoacoustics
12 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce a sales collaboration with Optoacoustics Ltd, the world leader in innovative, high performance optical communication solutions for magnetic resonance (MR) applications.
Imricor Announces First Sales Collaboration with Philips
4 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first sales collaboration with Philips, a global leader in healthcare technology.
Amsterdam UMC Becomes First to Perform Cardiac Catheter Ablation in Diagnostic MRI Lab
23 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedure using the Company’s products in a traditional diagnostic MRI lab have been performed at the Amsterdam University Medical Center.
Haga Hospital Becomes First in the Benelux To Perform Cardiac Catheter Ablation in the iCMR
5 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce, the first two successful cardiac catheter ablation procedures using the Company’s product at the Haga Hospital. These procedures are a first for heart care in the Benelux.